New Experimental Drugs Aim to Surpass Current GLP-1 Weight-Loss Therapies

A new generation of weight-loss therapies is under development, promising to offer improved efficacy and convenience compared to existing GLP-1 drugs like Zepbound and Wegovy.

6 Jun, 18:53 — 6 Jun, 18:53

Post Share

Sources

Showing 1 of 1 sources

marketwatchMostly Factual1h ago

Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy.

There is a new wave of weight-loss therapies in development that aim to be better than the existing GLP-1s.

By Jaimy Lee

Read full article →

PERSPECTA

PERSPECTA

New Experimental Drugs Aim to Surpass Current GLP-1 Weight-Loss Therapies

Sources

Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy.

Related Stories

Extreme Training: What Heat Training Does to the Body

Organ Donor Registrations Surge in Norway After Crown Princess Mette-Marit's Illness Revelation

New Urine Test Developed for Early Autism Diagnosis

Study Questions Reliability of Mental Health Diagnosis Interviews

PERSPECTA